Monoclonal Antibody Therapy Industry Overview & Strategic Insights
According to FutureWise analysis the market for monoclonal antibody therapy in 2026 is US$ 359.42 billion, and is expected to reach US$ 1028.77 billion by 2036 at a CAGR of 11.09%. The growth in monoclonal antibodies is attributed to their expanding use in oncology, autoimmune disorders, infectious diseases, and rare genetic conditions. Advances in antibody engineering, biosimilars, and...
0 Comments 0 Shares 176 Views 0 Reviews
Sponsored